Skip to search formSkip to main contentSkip to account menu

MK 507

Known as: MK-507 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
We compared the effect on intraocular pressure (IOP) of maximal doses of a topical carbonic anhydrase inhibitor (CAI) at acidic… 
1996
1996
BACKGROUND Since the introduction of carbonic anhydrase inhibitors, a topical preparation has been sought to avoid the… 
1995
1995
PurposeThe purpose of this study was to examine the long-term efficacy and safety of dorzolamide (a topical carbonic anhydrase… 
1994
1994
The effects of the topical carbonic anhydrase inhibitor, MK-507, on aqueous humor dynamics were studied in 6 normal volunteers… 
1994
1994
3-Aminoalkyl derivatives of thieno[2,3-b][1,4]thiazine-6-sulfonamide were prepared for evaluation as topically active ocular… 
1994
1994
The effects of topical carbonic anhydrase inhibitor (MK-507) on intraocular pressure (IOP) were studied in normal human eyes. The… 
Review
1992
Review
1992
Oral carbonic anhydrase inhibitors have been used extensively in the treatment of all types of glaucoma. These agents reduce… 
1991
1991
A three-dose, randomized, double-blind parallel, placebo-controlled ocular tolerancy study was undertaken in 24 healthy, normal… 
1991
1991
Experiments were undertaken in normal albino rabbits to determine if cyclooxygenase inhibition by nonsteroidal anti-inflammatory…